The potential harms of sedentary behaviour on cardiometabolic health are mitigated in highly active adults: a compositional data analysis

Table 2 Cardiometabolic risk factors between groups with low, intermediate and high sedentary time

	Low (n = 20)	Intermediate (n = 20)	High (n = 21)	p-value
Cardiovascular health
Systolic blood pressure (mm Hg)	118 ± 10	120 ± 14	118 ± 10	0.818
Diastolic blood pressure (mm Hg)	71 ± 9	73 ± 7	71 ± 7	0.553
Mean arterial pressure (mm Hg)	87 ± 9	89 ± 8	87 ± 7	0.600
Resting heart rate (bpm)	62 ± 6	61 ± 7	59 ± 9	0.129
Total cholesterol (mmol/L)	4.27 ± 0.65	4.22 ± 0.77	4.05 ± 0.82	0.619
HDL cholesterol (mmol/L)	1.61 ± 0.47	1.47 ± 0.28	1.62 ± 0.43	0.402
LDL-cholesterol (mmol/L)	2.30 ± 0.46	2.34 ± 0.75	2.04 ± 0.67	0.446
Triglycerides (mmol/L)	0.75 ± 0.22	0.89 ± 0.27	0.81 ± 0.24	0.190
CCMR	− 0.03 ± 0.63	0.12 ± 0.78	− 0.09 ± 0.41	0.547
Glucose tolerance
Fasting glucose (mmol/L)	5.2 ± 0.4	5.1 ± 0.4	5.1 ± 0.3	0.963
Fasting insulin (pmol/L)	56 ± 57	45 ± 20	44 ± 28	0.574
Glucose 120 min (mmol/L)	4.9 ± 1.4	5.1 ± 1.2	5.3 ± 1.5	0.738
Insulin 120 min (pmol/L)^a	139 ± 70	189 ± 101	188 ± 139	0.511
Matsuda index	8.16 ± 2.89	8.42 ± 3.90	8.47 ± 3.21	0.955
IGI^a	90 ± 112	80 ± 122	142 ± 76	0.103
HOMA-IR^a	1.44 ± 0.51	1.49 ± 0.77	1.47 ± 0.98	0.979
HOMA-B (%)^a	101.3 ± 101.9	80.7 ± 29.5	77.9 ± 42.2	0.468
mISI	0.37 ± 0.24	0.29 ± 0.15	0.33 ± 0.19	0.476
HIRI	21.8 ± 8.2	24.8 ± 6.6	27.0 ± 5.2	0.056

Data are expressed as mean ± SD
BP blood pressure, bpm beats per minute, CCMR clustered cardiometabolic risk score, HDL high-density lipoprotein, HIRI hepatic insulin resistance index, HOMA-B homeostatic model assessment of β-cell function, HOMA-IR homeostatic model assessment of insulin resistance, HOMA-S homeostatic model assessment of insulin sensitivity, IGI insulinogenic index, LDL low-density lipoprotein, mISI muscle insulin sensitivity index
*p < 0.05. ^aDifferences between groups were assessed using the Kruskal–Wallis test due to the abnormal distribution of the data

ISSN: 2731-4391